FolioLanternBeta
MRNAModerna

Noubar Afeyan

Director at Moderna, as of May 22, 2026In the past 12 months: bought $50.0M of stock in 2 open-market purchases.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
2.22M
shares held after the latest filing, Moderna
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
$50.0M
open-market purchases, past 12 months (2 trades)
2
companies filed for

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Moderna (MRNA)DirectorDec 7, 2018May 22, 2026
Generate Biomedicines, Inc. (GENB)DirectorFeb 26, 2026Mar 12, 2026

Also a director at

Generate Biomedicines, Inc. (GENB)

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.